FADD and rheumatoid arthritis: Based on the facts mentioned above, the present study aimed to explore the molecular epigenetic regulation of FADD expressions by targeting miRNA 128a, which could be a unique diagnostic biomarker in RA and a potential target for therapeutic intervention.